Merck & Co., Inc. - Company & Market Research Reports

Home /
Companies /
Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 334
Infectious Diseases Drugs 245
Vaccines 240
Animal Healthcare/Veterinary 191
Endocrine and Metabolic Disorders Drugs 175
Immune Disorders Drugs 154
Animal Pharmaceuticals 135
Central Nervous System Drugs 133
Women's Health 132
Cardiovascular Drugs 126
Pharmaceuticals 112
Musculoskeletal Disorders Drugs 103
Drug Discovery 98
Biopharmaceuticals 95
Respiratory Drugs 81
Oncology 74
Clinical Trials 72
Allergy and Immunology 71
Sexual and Reproductive Health Drugs 71
Liver and Kidney Disorders Drugs 69
Diabetes Drugs 67
Antibiotics 62
Gastrointestinal Drugs 61
Biotechnology 60
Drug Delivery 59
Enzymes 57
Genomics 48
Analgesics 43
Optical Disorders Drugs 42
Dermatological Drugs 42
Brain Cancer Drugs 41
Skin Cancer Drugs 39
Infusions and Injectables 36
Diagnostics 36
Lymphoma Drugs 35
Pulmonary Medicine 34
Cancer Vaccines 33
Pharmaceutical Intermediates 32
Hematological Drugs 32
Biosimilars and Biosuperiors 32
Lung Cancer Drugs 30
Urological Disorders Drugs 29
Optical 28
HIV/AIDS Drugs 28
Pharmaceutical Manufacturing 28
Liver Cancer Drugs 26
Healthcare Services 25
Over the Counter (OTC) Drugs 25
Immunosuppressive Drugs 24
Neurology 23
Prostate Cancer Drugs 23
Infectious Disease Testing 23
Cervical Cancer Drugs 22
Allergy Drugs 22
Breast Cancer Drugs 21
Leukemia Drugs 21
Cardiology 21
Mental Disorders Drugs 19
Psoriasis Drugs 19
Asthma Drugs 18
Colon Cancer Drugs 17
Vitamins and Dietary Supplements 17
Drugs by Therapeutic Area 16
Inhalers and Nebulisers 16
Dermatology 16
E-Healthcare 15
Bladder Cancer Drugs 15
Medical Devices 15
Biomarkers 15
Gastroenterology 14
Fertility Services 13
Ovarian Cancer Drugs 13
Hematology 13
Pancreatic Cancer Drugs 13
Pediatrics 13
Alzheimer's Disease Drugs 13
Urology and Nephrology 12
Nanomedicine 12
Therapeutic Area 11
Generic Drugs 11
Transdermal and Transmucosal Drug Delivery 11
Kidney Cancer Drugs 11
Anti-Obesity Drugs 11
Respiratory Devices 10
Thyroid Cancer Drugs 10
In Vitro Diagnostics 9
Anesthetic Drugs 8
Mental Health 8
Uterine Cancer Drugs 7
Bronchitis Drugs 7
Proteomics 6
Healthcare 6
Other Healthcare Facilities 6
Laboratory Equipment 6
Endocrinology 6
Company Reports 5
Hepatology 5
Needles and Syringes 5
Cough and Cold Drugs 4
Surgical Procedures 4
Cardiovascular Devices 3
Diabetes Devices 3
Hospital Management 3
Molecular Diagnostics 3
Palliative Care 3
Acne Drugs 3
Anxiety Drugs 3
Schizophrenia Drugs 3
Addiction Disorders Drugs 2
Patient Monitoring Equipment 2
Pharmacoeconomics 2
Laboratory Testing 2
Dental 2
Mammography 2
Stem Cells 2
Blood Banking 2
Biomaterials 2
ENT Devices 2
Nursing 2
Surgical Devices 2
Endoscopy 2
Clinical Skills 2
Maternal and Neonatal Care 2
Orthopedic Devices 1
Dialysis 1
Cholesterol Testing 1
Managed Care 1
Neurology Devices 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Anatomy 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

3,382 Results (Page 33 of 170)
- Relevance
  Sort by

HDAC Inhibitors Market 2023-2027

 Report
January 2023
157 Pages
Global

From

€2237EUR$2,500USD£1,913GBP

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1588 Pages
Global

From

€2237EUR$2,500USD£1,913GBP

Colon Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
746 Pages
Global

From

€2237EUR$2,500USD£1,913GBP

Pediatric Neuroblastoma Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4017EUR$4,490USD£3,436GBP

Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2025

 Clinical Trials
June 2025
281 Pages
Global

From

€3087EUR$3,450USD£2,640GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Bone Marrow Aspirate Concentrates Market - Global Forecast 2026-2032

 Report
January 2026
181 Pages
Global

From

€3172EUR$3,545USD£2,713GBP

€3524EUR$3,939USD£3,014GBP

Lambert-Eaton Myasthenic Syndrome Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
119 Pages
Global

From

€4026EUR$4,500USD£3,443GBP

H1N1 Vaccines - Global Strategic Business Report

 Report
August 2026
268 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Hepatitis B Vaccines - Global Strategic Business Report

 Report
August 2026
434 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

DNA Vaccines Market - Global Strategic Business Report

 Report
August 2026
171 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Bacterial Vaccines Market - Global Strategic Business Report

 Report
August 2026
490 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Adult Vaccines Market - Global Strategic Business Report

 Report
August 2026
377 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Adenovirus Vaccines Market - Global Strategic Business Report

 Report
August 2026
279 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Hepatitis A Vaccines Market - Global Strategic Business Report

 Report
August 2026
282 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Malaria Vaccines Market - Global Strategic Business Report

 Report
August 2026
371 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Multivalent Vaccines Market - Global Strategic Business Report

 Report
August 2026
278 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Mumps Vaccines Market - Global Strategic Business Report

 Report
August 2026
288 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Chickenpox Vaccines Market - Global Strategic Business Report

 Report
August 2026
374 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Toxoid Vaccines Market - Global Strategic Business Report

 Report
August 2026
282 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Respiratory Virus Vaccines Market - Global Strategic Business Report

 Report
August 2026
474 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

3,382 Results (Page 33 of 170)
- 1
- 31
- 32
- 33
- 34
- 35

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.